The Reappraisal of Neuropeptide Y as Biomarker and Therapeutic Target in Arrhythmic Disorders

By sjmartinez • March 17, 2025

Zaglia T, Ajijola OA. The Reappraisal of Neuropeptide Y as Biomarker and Therapeutic Target in Arrhythmic Disorders. JACC Clin Electrophysiol. 2025 Feb 24:S2405-500X(25)00068-4. doi: 10.1016/j.jacep.2025.01.012. Epub ahead of print. PMID: 40088221.

Tags: Cardiology/Epi, neuropeptide Y, Publications, sympathetic nervous system, Ventricular arrhythmias

Related Posts

Artificial intelligence-derived splenic response in cardiac positron emission tomography is associated with major adverse cardiovascular events: a multi-site study

Ramirez G, Dharmavaram NL, Shanbhag A, Miller RJH, Kavanagh PB, Yi J, Lemley M, Builoff V, Marcinkiewicz A, Dey D, Hainer J, Wopperer S, Knight[...]

Biomarkers associated with efficacy of first-line nivolumab vs. sorafenib in advanced hepatocellular carcinoma: results from the CheckMate 459 phase III trial

Neely J, Yao J, Kudo M, Finn RS, Sangro B, Melero I, El-Khoueiry AB, Yau T, Harding JJ, Rosmorduc O, Tschaika M, Novosiadly R, Cruz[...]

Deep learning-enabled screening of chronic kidney disease from echocardiography

Yuan V, Ieki H, Sandhu A, Nguyen LH, Cheng PP, Chang ST, Ambrosy AP, Kwan AC, Go AS, Cheng S, Ouyang D. Deep learning-enabled screening[...]